Markets have been really bad at coming with solutions (a) for chronically vulnerable groups, (b) for problems which develop over too long a time period to become urgent, and (c) by replacing reactive efforts with proactive efforts. MF seems to check all three of those boxes, while making sense as a business. Cool.
Can you say anything about how you expect these kinds of proactive diagnostics to interact with the existing insurance ecosystem, which tends to pay for diagnosis but varies a lot on treatment?
Can you say anything about how you expect these kinds of proactive diagnostics to interact with the existing insurance ecosystem, which tends to pay for diagnosis but varies a lot on treatment?